- Tweets 647
- Following 271
- Followers 1,090
- Likes 538
ALT Parents holding babies and the text 'The study aims to improve our understanding of how to diagnose and treat rare genetic conditions by sequencing newborns’ genomes.'
ALT Parents holding babies and the text 'It will also support research into genetic conditions and explore the potential of storing a genome over a person’s lifetime.'
ALT Parents holding babies and the text 'Parents at participating NHS Trusts will be asked if they wish to join from approximately 20 weeks of pregnancy.'
ALT Parents holding babies and the text 'The study was designed in collaboration with the public, parents, healthcare professionals and people from the rare disease community.'
ALT Light blue background with text: Ten years ago, Genomics England was formed to deliver the 100,000 Genomes Project. The NHS is now the first healthcare system in the world to offer whole genome sequencing as part of routine care. A green circle and light blue pill-shape adorn the top right corner of the graphic.
ALT Light blue background with a green circle, pink half circle, and light blue pill-shape with the text: It's been a revolutionary decade. We want to thank every participant and patient who informed us along the way and trusted us with their data.
ALT Light blue background with text: Today, 10 years from our start... In a green pill-shape are the words: 5% to 55% of participants (depending on clinical area) received a finding that was clinically relevant to their cancer or rare condition In a blue pill-shape are the words: Nearly 2,200 approved academic and life sciences researchers conducting potentially life-changing research on the data. A pink pill shape with the text: >2,200 potential diagnoses identified via research. In a yellow pill shape is the text: 140,500 genomes in the National Genomic Research Library
ALT Light blue background with a 3 half circles in yellow, pink and light blue with text: We're proud of everything we've accomplished with the NHS, but there's still more to do. We look forward to what the next decade of genomic healthcare will hold.
